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Background
Surveillance is cost-effective in surgery. It's shown to
decrease surgical site infections (SSI's) and other surgery
related complications. SSI rate is considered a quality care
index. The objective of this study was to describe a 5-year
experience with a continuous, prospective surveillance
program in patients undergoing mastectomy.
Methods
Since 2000, when poor compliance to infection control
policies and high rates of infection (SSI:33.1%) were
detected at the Breast Tumor Department, surveillance has
been conducted by direct observation along with sur-
geons. Preventive policies were introduced in 2001 (strict
prophylactic antibiotics, closed suction drains and feed-
back to surgeons). In 2004 we studied perioperative
hyperglycemia as a risk factor for SSI in selected patients.
We constructed control charts for SSI analysis. Univariate
and stratified analysis were performed.
Results
2340 surgeries were monitored. After the introduction of
preventive policies, SSI's dropped 50%. In 2001 and 2002
SSI remained within acceptable limits, but in 2003 we
observed 2 peaks of SSI above control limits. These peaks
were linked to poor quality drainages (OR = 1.96, 95% CI
= 1.2–3.3, p = 0.004) and low performance of surgical res-
idents. At the end of 2004 another peak of SSI was
observed when J-Vac® was introduced without personal
training. Antibiotic prophylaxis was prescribed in accord-
ance to guidelines in 2001 (95%) patients, and 62% was
timeliness. In patients in which perioperative glucose was
determined (n = 260), we observed that any glucose
>=150 mg/dL, increased the risk of SSI (OR = 3.05 95% CI
= 1.5–6.3, p = 0.006).
Conclusion
Preventive policies were effective in reducing SSI. Contin-
uous and prospective surveillance detected an increase on
complications related to poor quality and inappropriate
drainages. Perioperative glucose values >150 mg/dL
seems to be associated with an increased risk of SSI in
patients undergoing mastectomy. Surveillance is manda-
tory to ensure appropriate quality standards.
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